Company profile
Llusern Scientific molecular diagnostics for point of care testing.
Llusern Scientific is a manufacturer and distributor of POCT molecular diagnostic assays for UTIs for use in human and veterinary medicine.
Financial period: 1 May 2024 to 30 Apr 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
CH01 | Transaction MzUyOTQzODIzOGFkaXF6a2N4
Published 01 Jul 2026 10:18
SH01 | Transaction MzUyNzc0NzM2MmFkaXF6a2N4
Published 22 Jun 2026 11:10
Last confirmation statement made up date
Last accounts made up date
AP01 | Transaction MzQ0MDI4NjgzNmFkaXF6a2N4
Published 21 Oct 2024 10:56
AA | Transaction MzQzMzQ3MzY0OWFkaXF6a2N4
Published 27 Aug 2024 14:02
CS01 | Transaction MzQzMTY5ODE1MGFkaXF6a2N4
Published 09 Aug 2024 08:18
Company registered at Companies House
1 Apr 2022 to 31 Mar 2023
I am Emma Hayhurst, co-founder and CEO of Llusern Scientific. Llusern's purpose is to address inequalities in healthcare by overcoming barriers to accurate diagnostics -- giving everyone the chance to be diagnosed properly when they need to be. We have developed a novel molecular diagnostic testing device which can be used for the diagnosis of Covid-19\. ...
